Hiromi Saito Selected Research

Hiromi Saito Research Topics

3	Hyperlipidemias (Hyperlipidemia) 01/2015 - 01/2013
3	Body Weight (Weight, Body) 01/2015 - 01/2013
2	Fibrosis (Cirrhosis) 06/2021 - 11/2019
2	Neoplasms (Cancer) 11/2014 - 11/2010
2	Mesothelioma 03/2013 - 11/2010
1	Ulcer 01/2022
1	Nasal Polyps (Nasal Polyp) 11/2021
1	Rhinosinusitis 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Shock 01/2021
1	Infections 04/2018
1	Chronic Hepatitis C 04/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Leukemia 11/2014
1	Synovial Sarcoma (Synovioma) 09/2013
1	Rheumatoid Arthritis 09/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010

3	HLA-Bw4 antigenIBA 06/2021 - 01/2018
3	FructoseIBA 01/2015 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
2	ChylomicronsIBA 01/2015 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 01/2015
2	Lipoproteins (Lipoprotein)IBA 01/2015 - 01/2015
2	SugarsIBA 01/2015 - 01/2015
1	Adalimumab (Humira)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 11/2021
1	benralizumabIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	SaltsIBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 11/2019
1	micaIBA 04/2018
1	KIR ReceptorsIBA 01/2018
1	AmphiregulinIBA 11/2014
1	Adenosine Triphosphatases (ATPase)IBA 11/2014
1	InterleukinsIBA 11/2014
1	Dimethylglycine DehydrogenaseIBA 11/2014
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2013
1	A-Form DNA (A-DNA)IBA 03/2013
1	Apolipoprotein E3IBA 01/2013
1	Lovastatin (Mevacor)FDA LinkGeneric 11/2010
1	Cantharidin (Cantharides)IBA 11/2010
1	CholesterolIBA 11/2010
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 11/2010

1	Drug Therapy (Chemotherapy) 09/2013